Phase II Study Of Single-Agent SU011248 In The Second-Line Treatment Of Patients With Metastatic Renal Cell Carcinoma
收藏DataCite Commons2025-05-01 更新2024-07-13 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006797/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary goal of the study is to evaluate the effectiveness and safety of SU-011,248 as a
treatment for metastatic kidney cancer.
提供机构：
Vivli
创建时间：
2021-04-02
